Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kingstone Companies (KINS) Asset Writedowns and Impairment (2022 - 2025)

Historic Asset Writedowns and Impairment for Kingstone Companies (KINS) over the last 4 years, with Q3 2025 value amounting to $27131.0.

  • Kingstone Companies' Asset Writedowns and Impairment fell 1361.75% to $27131.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $126388.0, marking a year-over-year increase of 2465.65%. This contributed to the annual value of $115470.0 for FY2024, which is 5351.99% up from last year.
  • Latest data reveals that Kingstone Companies reported Asset Writedowns and Impairment of $27131.0 as of Q3 2025, which was down 1361.75% from $26443.0 recorded in Q2 2025.
  • Kingstone Companies' 5-year Asset Writedowns and Impairment high stood at $89212.0 for Q4 2022, and its period low was $1139.0 during Q3 2022.
  • Moreover, its 4-year median value for Asset Writedowns and Impairment was $26443.0 (2025), whereas its average is $27963.5.
  • Examining YoY changes over the last 5 years, Kingstone Companies' Asset Writedowns and Impairment showed a top increase of 171729.59% in 2023 and a maximum decrease of 8193.52% in 2023.
  • Over the past 4 years, Kingstone Companies' Asset Writedowns and Impairment (Quarter) stood at $89212.0 in 2022, then tumbled by 81.94% to $16116.0 in 2023, then skyrocketed by 87.37% to $30197.0 in 2024, then decreased by 10.15% to $27131.0 in 2025.
  • Its Asset Writedowns and Impairment was $27131.0 in Q3 2025, compared to $26443.0 in Q2 2025 and $42617.0 in Q1 2025.